Celltrion to build 112 billion won GMP plant in Ochang

Published: 2012-05-16 06:56:00

Updated: 2012-05-16 06:56:00

Celltrion, the nation’s foremost biosimilar producer, said yesterday in a regulatory filing that it plans to build a 112 billion won GMP (Good Manufacturing Practice) plant in Ochang, North Chungcheong Province, to make inroads to new emerging markets.

According to the company, the production ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK